Loading clinical trials...
Loading clinical trials...
Evaluating the Use of Repetitive Transcranial Magnetic Stimulation in Cancer Patients With Chemotherapy-Induced Peripheral Neuropathy: A Randomized Feasibility Study
Conditions
Interventions
Real repetitive transcranial magnetic stimulation
Sham repetitive transcranial magnetic stimulation
Start Date
December 1, 2022
Primary Completion Date
December 1, 2023
Completion Date
March 1, 2024
Last Updated
August 24, 2022
NCT07352514
NCT07064798
NCT07164950
NCT06994507
NCT04633655
NCT04970121
Lead Sponsor
The Hong Kong Polytechnic University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions